Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Pradines

Showing results (111-120 of 183) with videos related to

Pageof 19
Sort By:
Antimicrobial Agents and Chemotherapy|November 25, 2004
Polymorphism in plasmodium falciparum drug transporter proteins and reversal of in vitro chloroquine resistance by a 9,10-dihydroethanoanthracene derivativeJulie Millet, Sandrine Alibert, Marylin Torrentino-Madamet, et al.
Frontiers in Microbiology|May 23, 2022
Repurposing of Doxycycline to Hinder the Viral Replication of SARS-CoV-2: From <i>in silico</i> to <i>in vitro</i> ValidationRajaiah Alexpandi, Mathieu Gendrot, Gurusamy Abirami, et al.
Frontiers in Bioscience (Landmark Edition)|January 7, 2022
Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolatesCeline Boschi, Marion Le Bideau, Julien Andreani, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|September 11, 2008
Dihydroethanoanthracene derivatives reverse in vitro quinoline resistance in Plasmodium falciparum malariaMaud Henry, Sandrine Alibert, Meili Baragatti, et al.
Journal of Clinical Medicine|January 21, 2022
Exploratory Study on Application of MALDI-TOF-MS to Detect SARS-CoV-2 Infection in Human SalivaMonique Melo Costa, Hugo Martin, Bertrand Estellon, et al.
Malaria Journal|March 21, 2013
Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers studyBécaye Fall, Aurélie Pascual, Fatoumata D Sarr, et al.
Journal of Medicinal Chemistry|March 5, 2004
Orally active antimalarials: hydrolytically stable derivatives of 10-trifluoromethyl anhydrodihydroartemisininFabienne Grellepois, Fatima Chorki, Michèle Ourévitch, et al.
Journal of Clinical Medicine|July 24, 2021
In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2Mathieu Gendrot, Priscilla Jardot, Océane Delandre, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 VariantsOcéane Delandre, Mathieu Gendrot, Priscilla Jardot, et al.
Malaria Journal|April 7, 2017
Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian borderMohamed Salem Ould Ahmedou Salem, Khadijetou Mint Lekweiry, Houssem Bouchiba, et al.
Pageof 19

Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Antimicrobial Agents and Chemotherapy|November 25, 2004
Polymorphism in plasmodium falciparum drug transporter proteins and reversal of in vitro chloroquine resistance by a 9,10-dihydroethanoanthracene derivativeJulie Millet, Sandrine Alibert, Marylin Torrentino-Madamet, et al.
Frontiers in Microbiology|May 23, 2022
Repurposing of Doxycycline to Hinder the Viral Replication of SARS-CoV-2: From <i>in silico</i> to <i>in vitro</i> ValidationRajaiah Alexpandi, Mathieu Gendrot, Gurusamy Abirami, et al.
Frontiers in Bioscience (Landmark Edition)|January 7, 2022
Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolatesCeline Boschi, Marion Le Bideau, Julien Andreani, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|September 11, 2008
Dihydroethanoanthracene derivatives reverse in vitro quinoline resistance in Plasmodium falciparum malariaMaud Henry, Sandrine Alibert, Meili Baragatti, et al.
Journal of Clinical Medicine|January 21, 2022
Exploratory Study on Application of MALDI-TOF-MS to Detect SARS-CoV-2 Infection in Human SalivaMonique Melo Costa, Hugo Martin, Bertrand Estellon, et al.
Malaria Journal|March 21, 2013
Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers studyBécaye Fall, Aurélie Pascual, Fatoumata D Sarr, et al.
Journal of Medicinal Chemistry|March 5, 2004
Orally active antimalarials: hydrolytically stable derivatives of 10-trifluoromethyl anhydrodihydroartemisininFabienne Grellepois, Fatima Chorki, Michèle Ourévitch, et al.
Journal of Clinical Medicine|July 24, 2021
In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2Mathieu Gendrot, Priscilla Jardot, Océane Delandre, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 VariantsOcéane Delandre, Mathieu Gendrot, Priscilla Jardot, et al.
Malaria Journal|April 7, 2017
Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian borderMohamed Salem Ould Ahmedou Salem, Khadijetou Mint Lekweiry, Houssem Bouchiba, et al.
Pageof 19